TerminatedPhase 1NCT02460354
Metformin and Congenital Nephrogenic Diabetes Insipidus
Studying Arginine vasopressin resistance
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Emory University
- Principal Investigator
- Larry Greenbaum, MD, PhDEmory University
- Intervention
- Metformin(drug)
- Enrollment
- 2 enrolled
- Eligibility
- 18 years · MALE
- Timeline
- 2015 – 2017
Study locations (3)
- Childen's Healthcare of Atlanta, Atlanta, Georgia, United States
- Emory University Hospital - Atlanta Clinical and Translational Science Institute (ACTSI), Atlanta, Georgia, United States
- Emory University Hospital, Atlanta, Georgia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02460354 on ClinicalTrials.govOther trials for Arginine vasopressin resistance
Additional recruiting or active studies for the same condition.